Transit bipartition using a metallic anastomotic clip and circular fundocorporeal gastroplication
Official title: The Laparoscopic Transit Bipartition Without Gastrectomy With Use of Metallic Anastomosis Clip (MAC) and Circular Fundocorporeal Gastroplication for Treating Type 2 Diabetes Mellitus and Obesity
Run by The Society of Bariatric and Metabolic Surgeons of Kazakhstan · NCT07495020 · Data updated 2026-11-12
This trial tries a new metallic anastomotic clip to create a second stomach-to-ileum pathway to help adults with type 2 diabetes and BMI 25–34.9 improve blood sugar control.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | The Society of Bariatric and Metabolic Surgeons of Kazakhstan Academic / other |
| Locations | 1 site (Astana) |
| Status | Recruiting |
| Started | April 30, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | May 30, 2028 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT07495020 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with clinically diagnosed type 2 diabetes and BMI between 25 and 34.9 kg/m² who are not insulin dependent and are willing to undergo laparoscopic surgery are ideal candidates.
✕Probably not a fit
People with insulin‑dependent diabetes, prior stomach surgery, BMI outside 25–34.9 kg/m², severe psychiatric illness, or who cannot consent are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized controlled trial comparing three laparoscopic transit bipartition approaches that use a novel Metallic Anastomotic Clip (MAC) to form gastro‑ileal and entero‑enteric anastomoses. The procedure creates an additional food pathway while preserving normal duodenal digestion to stimulate GLP‑1 secretion and improve glucose metabolism without major malabsorption. One arm includes circular fundocorporeal gastroplication, another pairs the bypass with a sleeve gastrectomy, and a third uses the MAC without gastrectomy. The trial builds on a small pilot of 10 patients that showed technical feasibility and safety of the device.
Why it matters
Potential benefit: If successful, the device and procedure could offer durable blood sugar improvement for adults with type 2 diabetes who have overweight or Class I obesity but do not meet current BMI thresholds for bariatric surgery.
How similar studies have gone: Bariatric and metabolic surgical approaches, including transit bipartition concepts, have improved T2DM outcomes in prior work, and a small 10‑patient pilot with the MAC showed technical feasibility though larger randomized data are not yet available.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of Type 2 Diabetes Mellitus * BMI 25-35 kg/m2 Exclusion Criteria: * Insulin dependent diabetes * BMI \<25 and \>35 kg/m2 * History of surgery on the stomach * Less than 18 or more than 65 years of age * Psychiatric illness * Patients unwilling or unable to provide informed consent
Where it's running
-
Oral Ospanov
Astana, Kazakhstan Recruiting
Study contacts
- Principal investigator: Oral Ospanov, Professor — Astana Medical University
- Study coordinator: Oral Ospanov
- Email: bariatric.kz@gmail.com
- Phone: Astana, Kazakhstan, 010000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How incretin treatments affect muscle mass and function in people with overweight or obesity
This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.
-
Dose find for remimazolam plus alfentanil for gastroscopy in obese adults
This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.
-
Lifestyle change program to help type 2 diabetes go into remission in Pakistan
This study tests whether a structured, plant-predominant lifestyle program can put adults with type 2 diabetes in Lahore, Pakistan into remission for the first six months.
-
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults
This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.
-
Gut barrier and inflammation after fast-food overfeeding in adults
This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.